Stock Markets June 26, 2026 12:35 AM

Alibaba Shares Slide to Year Low After Anthropic Accusation and Pentagon Listing Dispute

Allegations of a large-scale AI 'distillation' attack and a lawsuit to contest a Pentagon designation pile on weak e-commerce metrics and broader Hong Kong market weakness

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn

Alibaba's stock tumbled to a fresh 52-week low after Anthropic accused operators tied to the company's Qwen AI lab of using nearly 25,000 fake accounts to flood the Claude model with tens of millions of requests, and as Alibaba filed a lawsuit seeking removal from the U.S. Department of Defense's "Chinese Military Companies" list. The combined reputational and legal pressures, alongside disappointing 618 shopping festival results and a weakening Hong Kong market, weighed heavily on the shares.

Alibaba Shares Slide to Year Low After Anthropic Accusation and Pentagon Listing Dispute
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Anthropic has formally accused operators linked to Alibaba's Qwen AI lab of using nearly 25,000 fraudulent accounts to send tens of millions of requests to the Claude model, targeting advanced capabilities including agentic reasoning and software engineering.
  • Alibaba filed a lawsuit seeking removal from the U.S. Department of Defense's "Chinese Military Companies" list, a designation that could lead to procurement bans and investment restrictions.
  • Weak results from China's 618 shopping festival and broad selling pressure in Hong Kong equities, including net selling via the northbound connect channel, compounded negative sentiment; competitors JD.com and Meituan are also facing headwinds.

Alibaba shares fell sharply on Friday, dropping 4.8% to HK$90.4 and briefly touching a new 52-week low of HK$89.2 as investors digested two significant headwinds: a formal allegation from AI developer Anthropic and a legal challenge against the U.S. Department of Defense.

The first and most immediate catalyst was a letter Anthropic sent to U.S. senators and White House officials that accused operators linked to Alibaba's Qwen AI lab of deploying nearly 25,000 fraudulent accounts to submit tens of millions of requests to Anthropic's Claude model. Anthropic said those requests systematically targeted the model's most advanced capabilities, including agentic reasoning and software engineering, and described the episode as the largest known AI distillation attack it has encountered.

Shortly after the AI controversy surfaced, Alibaba initiated legal action against the U.S. Department of Defense seeking to have itself removed from the Pentagon's "Chinese Military Companies" list. That designation carries the prospect of procurement bans and investment restrictions, creating an additional layer of regulatory risk for the company.

Market reaction to the pair of developments was severe. Alibaba's stock is trading roughly 50% below its October 2025 peak of HK$186.2, reflecting heightened investor concern around both reputational damage tied to the AI allegation and the potential economic consequences of the Pentagon listing.

Compounding the legal and reputational issues, Alibaba's core e-commerce business received little support from recent retail indicators. China's 618 shopping festival - a key sales period for the company - reported notably weak outcomes, with growth slowing sharply and offering limited offset to the negative headlines.

The broader Hong Kong equity complex has also been under pressure. The Hang Seng Index slipped below the 23,000 level in the prior session amid worries about Chinese technology names and substantial net selling by mainland Chinese investors through the northbound connect channel. That market backdrop has reduced the likelihood of sympathy buying for Alibaba.

Peers in the competitive Chinese e-commerce sector have not provided relief. Competitors such as JD.com and Meituan are also experiencing headwinds, leaving Alibaba without an immediate sector-led lift for its shares.


Contextual note: The facts above reflect the information available regarding the Anthropic accusation, Alibaba's lawsuit against the U.S. Department of Defense, recent trading moves, and 618 sales performance. Where details are limited in the available information, this article reports the stated claims and market reactions rather than drawing further inferences.

Risks

  • Reputational and legal exposure from the alleged large-scale AI distillation attack may damage investor confidence and customer relationships in the technology sector.
  • Regulatory and procurement risks tied to the Pentagon's "Chinese Military Companies" listing could constrain investment flows and commercial opportunities for Alibaba and potentially other Chinese tech firms.
  • Broader market weakness in Hong Kong and significant net selling by mainland investors could continue to depress valuations across Chinese technology and e-commerce stocks.

More from Stock Markets

Kioxia Plunges as AI Stock Selloff Follows OpenAI IPO Report Jun 26, 2026 TD Cowen Picks Rhythm Pharmaceuticals as Its Leading Biotech Investment Jun 26, 2026 SpaceX Mulls Direct-to-Consumer Starlink Mobile Service in U.S., May Build Terrestrial Network Jun 26, 2026 Samsung Electronics Plummets as Tech Sell-Off and Leveraged ETFs Amplify Losses Jun 26, 2026 KOSPI Plunges Over 8% as Tech and Chip Stocks Collapse, Trading Paused by Circuit Breaker Jun 26, 2026